CCA Health Initiative-
  • Home
  • About
  • Roadmap
  • Taskforce Members
  • Resources
    • Resources
    • News
  • Events
    • Past events
    • Upcoming events
  • Contact
CCA Health Initiative-
Pfizer’s Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk of Hospitalization or Death by 89%

Pfizer’s Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk of Hospitalization or Death by 89%

  • By External Content
  • December 6, 2021

PAXLOVIDâ„¢, significantly reduced hospitalization and death, based on an interim analysis of the Phase 2/3 EPIC-HR.

  • Home
  • About
  • Roadmap
  • Taskforce Members
  • Resources
    • Resources
    • News
  • Events
    • Past events
    • Upcoming events
  • Contact